WA
BSX icon

Wealth Alliance’s Boston Scientific BSX Stock Holding History

Wealth Alliance’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,500
Closed -$220K – 586
2026
Q1 		$220K Sell
3,500
-132
-4% -$10.6K 0.02% 518
2025
Q4 		$346K Sell
3,632
-31
-0.8% -$3.04K 0.03% 398
2025
Q3 		$358K Buy
3,663
+1,384
+61% +$143K 0.04% 375
2025
Q2 		$245K Buy
2,279
+37
+2% +$3.74K 0.03% 473
2025
Q1 		$226K Sell
2,242
-657
-23% -$66.2K 0.03% 472
2024
Q4 		$259K Sell
2,899
-173
-6% -$15.2K 0.03% 420
2024
Q3 		$257K Sell
3,072
-843
-22% -$66.5K 0.03% 437
2024
Q2 		$301K Sell
3,915
-521
-12% -$38.1K 0.04% 381
2024
Q1 		$304K Sell
4,436
-123
-3% -$7.91K 0.04% 397
2023
Q4 		$264K Sell
4,559
-154
-3% -$8.22K 0.04% 420
2023
Q3 		$249K Sell
4,713
-126
-3% -$6.61K 0.04% 406
2023
Q2 		$262K Buy
4,839
+325
+7% +$17K 0.04% 421
2023
Q1 		$226K Buy
+4,514
New +$213K 0.04% 441

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wealth Alliance's BSX Position: Q2 2026 in Review

Wealth Alliance sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,500 shares — an estimated $220K sold.

Wealth Alliance first reported a position in BSX in Q1 2023 and held it in 13 quarters. The position peaked at $358K in Q3 2025. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wealth Alliance reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Wealth Alliance sold 3,500 Boston Scientific shares in Q2 2026, an estimated $220K.
  • Wealth Alliance first reported a position in Boston Scientific in Q1 2023 and held it in 13 quarters.
  • Wealth Alliance's Boston Scientific position peaked at $358K in Q3 2025.
  • 1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.